Generated by GPT-5-mini| Wellcome Trust Research Career Re-entry Fellowships | |
|---|---|
| Name | Wellcome Trust Research Career Re-entry Fellowships |
| Type | Fellowship programme |
| Sponsor | Wellcome Trust |
| Country | United Kingdom |
| Established | 2000s |
| Purpose | Support researchers returning to research after a career break |
Wellcome Trust Research Career Re-entry Fellowships The Wellcome Trust Research Career Re-entry Fellowships were a targeted funding mechanism intended to enable researchers to resume independent research after an extended career break, with particular emphasis on biomedical and population health science. The awards sought to reduce attrition in research careers and to promote diversity by supporting applicants returning from long-term leave, aligning with broader initiatives from major funders and institutions across the United Kingdom and internationally.
The programme operated within the context of major biomedical funders and institutions such as Wellcome Trust, Medical Research Council, National Institute for Health and Care Research, European Research Council, Howard Hughes Medical Institute, and Gates Foundation, and intersected with policy debates involving Office for National Statistics, House of Commons Science and Technology Committee, Royal Society, Academy of Medical Sciences, and Nuffield Trust. Administratively, it paralleled career-return schemes run by Cancer Research UK, British Heart Foundation, National Institutes of Health, and European Molecular Biology Organization, and was informed by equality initiatives from Equality and Human Rights Commission, Athena SWAN, and Stonewall. The fellowship framework reflected practices at institutions such as University of Oxford, University of Cambridge, Imperial College London, University College London, and University of Edinburgh, and engaged professional networks including Royal College of Physicians and Society for Neuroscience.
Applicants typically were required to demonstrate a prior research track record with publications in outlets like Nature, Science, The Lancet, Cell, and Proceedings of the National Academy of Sciences, and to justify a career break due to reasons such as caring responsibilities, illness, or other personal circumstances linked to case law and employment practices considered by Employment Tribunal (England and Wales), Equality Act 2010, and guidance from European Commission. Applications required host institution endorsement from universities such as King's College London, University of Manchester, University of Glasgow, or research institutes like Francis Crick Institute, Sanger Institute, and required career development plans comparable to those for Marie Skłodowska-Curie Actions and NIH K-series. Eligibility cut-offs, eligibility windows, and allowed break durations were specified in alignment with practices seen at Wellcome Trust, European Research Council, Royal Society Dorothy Hodgkin Fellowships, and Leverhulme Trust awards.
Fellowships usually provided salary support, research expenses, and institutional contributions, paralleling funding formats from Medical Research Council, Wellcome Trust Senior Research Fellowships, and NIH Research Project Grants. Typical grant components included salary banding similar to contracts at University of Oxford, project costs for consumables and equipment comparable to Biotechnology and Biological Sciences Research Council grants, and modest support for childcare and flexible working arrangements reflecting policies from Wellcome Collection and institutional human resources units at Imperial College London. Duration and value levels were benchmarked against fellowships such as European Research Council Starting Grant, Gates Cambridge Scholarship, and NIH K99/R00 transition awards, and were administered with oversight comparable to peer review panels used by Medical Research Council and Wellcome Trust.
In addition to direct funding, fellows accessed mentoring, training, and reintegration support from career development services at University of Cambridge, University of Oxford, University College London, King's College London, and sector bodies such as Royal Society, Academy of Medical Sciences, British Heart Foundation, and Cancer Research UK. Professional development offerings included grant-writing workshops and leadership training modelled on programmes run by European Molecular Biology Organization, Gordon Research Conferences, Wellcome Genome Campus, and Cold Spring Harbor Laboratory. Host institutions often provided lab space at sites like Francis Crick Institute or computing resources at European Bioinformatics Institute, while appraisal and mentorship structures mirrored those advocated by UNESCO, OECD, and Research England.
Evaluations of similar career re-entry schemes showed effects on retention, publication outputs, and career progression comparable to findings reported by Royal Society, Academy of Medical Sciences, Wellcome Trust, and NIH. Outcomes tracked included subsequent competitive grants from bodies such as European Research Council, Medical Research Council, Wellcome Trust Investigator Awards, and National Institutes of Health, as well as appointments at institutions including University of Edinburgh, University of Glasgow, Imperial College London, and King's College London. Impact assessments referenced bibliometric indicators in databases maintained by Web of Science, Scopus, and PubMed Central, and policy analyses from King's Fund and Institute for Fiscal Studies.
Case studies highlighted individuals who re-established research trajectories and gained posts at leading centres such as Francis Crick Institute, Sanger Institute, Wellcome Trust Centre for Human Genetics, John Radcliffe Hospital, and Addenbrooke's Hospital, and who later received recognition from awardees lists maintained by Royal Society, Academy of Medical Sciences, European Research Council, and Wellcome Trust. Profiles often intersected with research themes connected to prominent figures and projects like Jennifer Doudna, Emmanuelle Charpentier, Sir Paul Nurse, Sir Tim Hunt, Francois Jacob, Sydney Brenner, James Watson, and major initiatives such as Human Genome Project, UK Biobank, 100,000 Genomes Project, and Human Cell Atlas.
Category:Fellowships